Cargando…
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis
INTRODUCTION: We aimed to describe healthcare resource utilization (HCRU) patterns and costs in patients with fibrosing interstitial lung disease (ILD) and those with a progressive phenotype of fibrosing ILD in a US claims database. METHODS: Data from the IBM(®) MarketScan(®) databases (1 October 20...
Autores principales: | Olson, Amy L., Hartmann, Nadine, Patnaik, Padmaja, Garry, Elizabeth M., Bohn, Rhonda L., Singer, David, Baldwin, Michael, Wallace, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990938/ https://www.ncbi.nlm.nih.gov/pubmed/35199282 http://dx.doi.org/10.1007/s12325-022-02066-9 |
Ejemplares similares
-
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis
por: Olson, Amy L., et al.
Publicado: (2021) -
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
por: Olson, Amy, et al.
Publicado: (2020) -
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020) -
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022) -
Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)